Simon Duchesne1, Yan Rolland, Marc Vérin. 1. Department of Radiology, Robert Giffard Research Center, Laval University, Quebec, PQ, Canada. duchesne@ieee.org
Abstract
RATIONALE AND OBJECTIVES: Reported error rates for initial clinical diagnosis of idiopathic Parkinson's disease (IPD) against other Parkinson Plus Syndromes (PPS) can reach up to 35%. Reducing this initial error rate is an important research goal. We evaluated the ability of an automated technique, based on structural, cross-sectional T1-weighted (T1w) magnetic resonance imaging, to perform differential classification of IPD patients versus those with either progressive supranuclear palsy (PSP) or multiple systems atrophy (MSA). MATERIALS AND METHODS: A total of 181 subjects were included in this retrospective study: 149 healthy controls, 16 IPD patients, and 16 patients diagnosed with either probable PSP (n = 8) or MSA (n = 8). Cross-sectional T1w magnetic resonance imagers were acquired and subsequently corrected, scaled, resampled, and aligned within a common referential space. Tissue composition and deformation features in the hindbrain region were then automatically extracted. Classification of patients was performed using a support vector machine with least-squares optimization within a multidimensional composition/deformation feature space built from the healthy subjects' data. Leave-one-out classification was used to avoid over-determination. RESULTS: There were no age difference between groups. The automated system obtained 91% accuracy (agreement with long-term clinical follow-up), 88% specificity, and 93% sensitivity. CONCLUSION: These results demonstrate that a classification approach based on quantitative parameters of three-dimensional hindbrain morphology extracted automatically from T1w magnetic resonance imaging has the potential to assist in the differential diagnosis of IPD versus PSP and MSA with high accuracy, therefore reducing the initial clinical error rate.
RATIONALE AND OBJECTIVES: Reported error rates for initial clinical diagnosis of idiopathic Parkinson's disease (IPD) against other Parkinson Plus Syndromes (PPS) can reach up to 35%. Reducing this initial error rate is an important research goal. We evaluated the ability of an automated technique, based on structural, cross-sectional T1-weighted (T1w) magnetic resonance imaging, to perform differential classification of IPD patients versus those with either progressive supranuclear palsy (PSP) or multiple systems atrophy (MSA). MATERIALS AND METHODS: A total of 181 subjects were included in this retrospective study: 149 healthy controls, 16 IPD patients, and 16 patients diagnosed with either probable PSP (n = 8) or MSA (n = 8). Cross-sectional T1w magnetic resonance imagers were acquired and subsequently corrected, scaled, resampled, and aligned within a common referential space. Tissue composition and deformation features in the hindbrain region were then automatically extracted. Classification of patients was performed using a support vector machine with least-squares optimization within a multidimensional composition/deformation feature space built from the healthy subjects' data. Leave-one-out classification was used to avoid over-determination. RESULTS: There were no age difference between groups. The automated system obtained 91% accuracy (agreement with long-term clinical follow-up), 88% specificity, and 93% sensitivity. CONCLUSION: These results demonstrate that a classification approach based on quantitative parameters of three-dimensional hindbrain morphology extracted automatically from T1w magnetic resonance imaging has the potential to assist in the differential diagnosis of IPD versus PSP and MSA with high accuracy, therefore reducing the initial clinical error rate.
Authors: Niels K Focke; Gunther Helms; Sebstian Scheewe; Pia M Pantel; Cornelius G Bachmann; Peter Dechent; Jens Ebentheuer; Alexander Mohr; Walter Paulus; Claudia Trenkwalder Journal: Hum Brain Mapp Date: 2011-01-18 Impact factor: 5.038
Authors: Sule Tinaz; Christopher Chow; Phillip H Kuo; Elizabeth A Krupinski; Hal Blumenfeld; Elan D Louis; George Zubal Journal: Clin Nucl Med Date: 2018-01 Impact factor: 7.794
Authors: Jennifer L Whitwell; Günter U Höglinger; Angelo Antonini; Yvette Bordelon; Adam L Boxer; Carlo Colosimo; Thilo van Eimeren; Lawrence I Golbe; Jan Kassubek; Carolin Kurz; Irene Litvan; Alexander Pantelyat; Gil Rabinovici; Gesine Respondek; Axel Rominger; James B Rowe; Maria Stamelou; Keith A Josephs Journal: Mov Disord Date: 2017-05-13 Impact factor: 10.338
Authors: Monika A Myszczynska; Poojitha N Ojamies; Alix M B Lacoste; Daniel Neil; Amir Saffari; Richard Mead; Guillaume M Hautbergue; Joanna D Holbrook; Laura Ferraiuolo Journal: Nat Rev Neurol Date: 2020-07-15 Impact factor: 42.937
Authors: Andre F Marquand; Maurizio Filippone; John Ashburner; Mark Girolami; Janaina Mourao-Miranda; Gareth J Barker; Steven C R Williams; P Nigel Leigh; Camilla R V Blain Journal: PLoS One Date: 2013-07-15 Impact factor: 3.240